Tissue Transglutaminase (tTG) Antibody, IgA
HER2/neu (ERBB2), IHC, Semi-Quantitative, Other Tissue
Biopsy, Endocervix
Fatty Acid Profile, Peroxisomal
Bromazepam
Vitamin K1
Botulinum Toxin Assay (CDC)
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
Osmolality, Serum
PAX2, Immunohistochemistry, Tissue
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
Medical Test
Additional Testing
Access to
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
is restricted.
Sign up now
Loading...